Download PDF
Thromb Haemost 2000; 83(02): 350-351
DOI: 10.1055/s-0037-1613815
Letters to the Editor
Schattauer GmbH

Evaluation of Lipoprotein(a) and Genetic Prothrombotic Risk Factors in Patients with Recurrent Foetal Loss

Ulrike Nowak-Göttl
1   From the Department of Paediatrics
,
Barbara Sonntag
2   Department of Gynaecology and Obstetrics, and the Institute of Clinical Chemistry and Laboratory Medicine
,
Ralf Junker
3   Institute of Arteriosclerosis Research, Westphalian Wilhelms-University Münster, Germany
,
Ulrich Cirkel
2   Department of Gynaecology and Obstetrics, and the Institute of Clinical Chemistry and Laboratory Medicine
,
Arnold von Eckardstein
3   Institute of Arteriosclerosis Research, Westphalian Wilhelms-University Münster, Germany
› Author Affiliations
Further Information

Publication History

Received 27 August 1999

Accepted after revision 22 October 1999

Publication Date:
11 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Brenner B, Sari G, Wiener Z, Yours J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with foetal loss without apparent cause. Thromb Haemost 1999; 82: 6-9.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Van Pampus MG, Koopmann MMW, Wolf H, Büller HR, Prins MH, van den Ende A. Lipoprotein(a) concentrations in women with a history of severe preeclampsia. Thromb Haemost 1999; 82: 10-3.
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Nowak-Göttl U, Wermes C, Junker R, Koch HG, Schobess R, Fleischhack G, Schwabe D, Ehrenforth S. Prospective evaluation of the prothrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR genotype, the prothrombin G20210A variant and further prothrombotic risk factors. Blood 1999; 93: 1595-9.
    PubMedSearch in Google Scholar
  • 4 Nowak-Göttl U, Junker R, Hartmeier M, Koch H-G, Münchow N, Assmann G, von Eckardstein A. Increased lipoprotein (a) is an important risk factor for thromboembolism in childhood. Circulation 1999; 100: 743-8.
    CrossrefPubMedSearch in Google Scholar
  • 5 Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 1997; 157: 1170-6.
    CrossrefPubMedSearch in Google Scholar
  • 6 Utermann G. The mysteries of lipoprotein (a). Science 1989; 246: 904-10.
    CrossrefPubMedSearch in Google Scholar
  • 7 Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52-60.
    CrossrefPubMedSearch in Google Scholar
  • 8 Hobbs H, White AL. Lipoprotein(a): intrigues and insights. Curr Opin Lipidol 1999; 10: 225-36.
    CrossrefPubMedSearch in Google Scholar
  • 9 Berg K, Roald B, Sande H. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Genet 1996; 50: 47-9.
    PubMedSearch in Google Scholar
  • 10 Haijjar KA, Nachman RL. The role of lipoprotein(a) in atherogenesis and thrombosis. Ann Rev Med 1996; 47: 423-42.
    CrossrefPubMedSearch in Google Scholar
  • 11 Taddei-Peters WC, Butman BT, Jones GR, Venetta TM, Macomber PF, Ransom JH. Quantification of lipoprotein (a) particles containing various apolipoprotein (a) isoforms by a monoclonal anti-apo (a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay. Clin Chem 1993; 07: 1382-9.
    PubMedSearch in Google Scholar